Fu S - Search Results

1

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.

Cascone T, Sacks RL, Subbiah IM, Drobnitzky N, Piha-Paul SA, Hong DS, Hess KR, Amini B, Bhatt T, Fu S, Naing A, Janku F, Karp D, Falchook GS, Conley AP, Sherman SI, Meric-Bernstam F, Ryan AJ, Heymach JV, Subbiah V. Cascone T, et al. Among authors: fu s. ESMO Open. 2021 Apr;6(2):100079. doi: 10.1016/j.esmoop.2021.100079. Epub 2021 Mar 12. ESMO Open. 2021. PMID: 33721621 Free PMC article. Clinical Trial.

2

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.

Wheler JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R. Wheler JJ, et al. Among authors: fu s. Ann Oncol. 2012 Aug;23(8):1963-1967. doi: 10.1093/annonc/mds027. Epub 2012 Feb 29. Ann Oncol. 2012. PMID: 22377564 Free PMC article.

3

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs.

Naing A, Veasey-Rodrigues H, Hong DS, Fu S, Falchook GS, Wheler JJ, Tsimberidou AM, Wen S, Fessahaye SN, Golden EC, Aaron J, Ewer MS, Kurzrock R. Naing A, et al. Among authors: fu s. Ann Oncol. 2012 Nov;23(11):2960-2963. doi: 10.1093/annonc/mds130. Epub 2012 Jun 27. Ann Oncol. 2012. PMID: 22745218 Free PMC article.

4

Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapy.

Wheler JJ, Falchook GS, Tsimberidou AM, Hong DS, Naing A, Piha-Paul SA, Chen SS, Fu S, Stephen B, Fok JY, Janku F, Kurzrock R. Wheler JJ, et al. Among authors: fu s. Ann Oncol. 2013 Mar;24(3):838-42. doi: 10.1093/annonc/mds524. Epub 2012 Nov 8. Ann Oncol. 2013. PMID: 23139256 Free PMC article.

5

Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma.

Naing A, Lorusso P, Fu S, Hong D, Chen HX, Doyle LA, Phan AT, Habra MA, Kurzrock R. Naing A, et al. Among authors: fu s. Br J Cancer. 2013 Mar 5;108(4):826-30. doi: 10.1038/bjc.2013.46. Epub 2013 Feb 14. Br J Cancer. 2013. PMID: 23412108 Free PMC article. Clinical Trial.

6

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

Henary H, Hong DS, Falchook GS, Tsimberidou A, George GC, Wen S, Wheler J, Fu S, Naing A, Piha-Paul S, Janku F, Kim KB, Hwu P, Kurzrock R. Henary H, et al. Among authors: fu s. Ann Oncol. 2013 Aug;24(8):2158-65. doi: 10.1093/annonc/mdt115. Epub 2013 Apr 10. Ann Oncol. 2013. PMID: 23576709 Free PMC article. Clinical Trial.

7

Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy.

Kurzrock R, Atkins J, Wheler J, Fu S, Naing A, Busaidy N, Hong D, Sherman S. Kurzrock R, et al. Among authors: fu s. Ann Oncol. 2013 Sep;24(9):2256-61. doi: 10.1093/annonc/mdt177. Epub 2013 May 14. Ann Oncol. 2013. PMID: 23676418 Free article. Clinical Trial.

8

Body composition and survival in the early clinical trials setting.

Veasey Rodrigues H, Baracos VE, Wheler JJ, Parsons HA, Hong DS, Naing A, Fu S, Falchoock G, Tsimberidou AM, Piha-Paul S, Chisholm G, Kurzrock R. Veasey Rodrigues H, et al. Among authors: fu s. Eur J Cancer. 2013 Oct;49(15):3068-75. doi: 10.1016/j.ejca.2013.06.026. Epub 2013 Jul 15. Eur J Cancer. 2013. PMID: 23867127

9

The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials.

Said R, Banchs J, Wheler J, Hess KR, Falchook G, Fu S, Naing A, Hong D, Piha-Paul S, Ye Y, Yeh E, Wolff RA, Tsimberidou AM. Said R, et al. Among authors: fu s. Ann Oncol. 2014 Jan;25(1):276-82. doi: 10.1093/annonc/mdt524. Ann Oncol. 2014. PMID: 24356639 Free PMC article.

10

First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.

Hong DS, Henary H, Falchook GS, Naing A, Fu S, Moulder S, Wheler JJ, Tsimberidou A, Durand JB, Khan R, Yang P, Johansen M, Newman RA, Kurzrock R. Hong DS, et al. Among authors: fu s. Invest New Drugs. 2014 Dec;32(6):1204-12. doi: 10.1007/s10637-014-0127-0. Epub 2014 Jun 13. Invest New Drugs. 2014. PMID: 24919855 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,382 results

Search Page

Filters